An object of the present invention is to elucidate the cause of degradation of the reliability of detecting causative bacteria of environmental mastitis such as Escherichia coli, Klebsiella bacteria, Streptococcus bacteria, and CNS, and to provide a highly reliable detection means. Another object of the present invention is to provide a highly reliable detection means based on the immunochromatographic method, which enables quicker determination compared with the cultivation-based method, and a diagnosis kit using it. The present invention provides a method for detecting a causative bacterium of environmental mastitis of a livestock animal, which comprises: the step of determining whether number of the causative bacterium in a milk of a subject livestock animal is not smaller than a determination value defined beforehand on the basis of distribution of amounts of the causative bacterium in milks derived from a non-disease group and distribution of the amounts of causative bacterium in milks derived from a disease group by an immunological test method, and wherein the immunological test method is an immunochromatographic method using an antibody labeled with not less than 0.6/cm.sup.2 and not more than 3.5/cm.sup.2 of gold colloid particles (particle-labeled antibody).

Server apparatus, by controlling aerial vehicle, causes aerial vehicle to fly within a close range of an animal group, and causes aerial vehicle to capture images of the animal group. Aerial vehicle transmits captured image data to server apparatus via communication network, and server apparatus checks a health state of animals of the animal group using the captured image data with a method such as image analysis. Server apparatus performs machine learning using position information history of wireless terminals attached to animals (that is, a movement history of the animal group), specifies an area for checking the state of the animal group, and causes aerial vehicle to fly to the specified area and to capture images of the animal group.

A veterinary bromhexine hydrochloride soluble powder, a preparation method and use thereof are disclosed. The method includes: (1) weighing a prescription amount of bromhexine hydrochloride and a part of prescription amount of citric acid, performing a primary mixing, pulverizing, sieving and dividing the mixed material into three equal parts; (2) weighing a remaining prescription amount of citric acid, pulverizing, sieving and dividing it into three equal parts; (3) weighing a prescription amount of lactose, sieving, and weighing three parts of the lactose accounting for 10% of the total amount; (4) putting one part of the mixed material obtained in “1”, one part of citric acid obtained in “2” and one part of lactose obtained in “3” alternately into a multi-directional motion mixer; (5) notifying an QA to inspect semi-finished products; and (6) packaging qualified semi-finished products, and warehousing qualified finished products.

The present disclosure relates to a composition comprising a Lactobacillus plantarum CJLP475 strain deposited under Accession No. KCCM12287P; and a Lactobacillus plantarum CJLPl7 strain deposited under Accession No. KCCM12249P, and use thereof.

A structure for sheltering and cooling livestock may include a concrete floored barn having an improved evaporative cooling system. The cooling system may include a misting stack having air inlets, a mixing chamber, and three cooling zones wherein the cooling zones correspond to three different temperature ranges. Each of the cooling zones may include a plurality of nozzles which produce a mist. As air passes through the mixing chamber, the mist may evaporate and cool the air. The cooling system may further include a plurality of large exhaust fans located at an end of the barn distal from the misting stack. The fans may draw the cool air through the barn, over and around the livestock, and out of the barn.

Provided are compositions for increasing the half-life of a polypeptide or polypeptides in a livestock animal and methods of their use. The compositions involve variant IgG Fc regions.

The present invention relates in general to a biosecurity system for the livestock industry, and more specifically, animal production facilities. The livestock biosecurity system comprises a biometric recognition component, a cloud database, and a smart device (e.g., smartphone, tablet, laptop, etc.). A purpose of the livestock biosecurity system is to track person(s) of interest and verify that persons of interest attempting to gain access to an animal production facility are compliant with pre-set biosecurity protocols. The livestock biosecurity system determines whether the person(s) of interest should or should not be granted entry into an animal production facility based on the preset biosecurity protocols and further provides employee oversight at the facility.

A medical institution to easily conduct medical examination regarding an animal. An animal medical care support system that supports medical care of an animal, the system comprising: a medical inquiry storage unit that stores question items in association with animal species; an animal species specifying unit that specifies the animal species of the animal scheduled to receive medical examination at a veterinary medical institution; a question transmission unit that reads out the question items corresponding to the specified animal species and transmits them to a portable terminal operated by a breeder of the animal; an answer reception unit that receives answers to the question items from the portable terminal; and an answer output unit that outputs the answer to a medical terminal of a medical personnel of the veterinary medical institution.

Antimicrobial peptides (AMPs), small compounds that often exhibitbroad spectrum antimicrobial activity, are garnering interest as potential therapeutics against antibiotic-resistant bacterial pathogens. Development of new AMPs is arduous due to the practical limitations of classical protein-based discovery approaches. A high throughput bioinformatics approach is described which is able to confirm identification of known AMPs from the North American bullfrog (Rana (Lithobates) catesbeiana) genome, and a bioinformatics approach is used to develop new AMPs. The described AMPs exhibit antimicrobial activity against Mycobacterium smegmatis via microtitre broth dilution assays, indicating broader efficacy.

Provided herein are pharmaceutical compositions comprising tumoricidal and/or antimicrobial components isolated from the supernatant of NK-92 cell medium and methods of using the compositions for killing cancer cells.